A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Atrion Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 2,018 shares of ATRI stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,018
Holding current value
$0
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$381.09 - $495.99 $769,039 - $1 Million
2,018 New
2,018 $913,000
Q3 2022

Nov 14, 2022

BUY
$545.43 - $680.3 $171,265 - $213,614
314 Added 9.32%
3,683 $2.08 Million
Q2 2022

Aug 15, 2022

SELL
$605.0 - $763.25 $105,875 - $133,568
-175 Reduced 4.94%
3,369 $2.12 Million
Q1 2022

May 16, 2022

SELL
$601.4 - $763.0 $524,420 - $665,336
-872 Reduced 19.75%
3,544 $2.53 Million
Q4 2021

Feb 14, 2022

SELL
$650.15 - $802.0 $1.51 Million - $1.86 Million
-2,322 Reduced 34.46%
4,416 $0
Q3 2021

Nov 15, 2021

BUY
$594.24 - $758.0 $1.38 Million - $1.76 Million
2,327 Added 52.75%
6,738 $4.7 Million
Q2 2021

Aug 16, 2021

BUY
$582.88 - $670.99 $985,067 - $1.13 Million
1,690 Added 62.11%
4,411 $0
Q1 2021

May 17, 2021

SELL
$619.2 - $736.0 $433,440 - $515,200
-700 Reduced 20.46%
2,721 $1.75 Million
Q4 2020

Feb 16, 2021

SELL
$576.6 - $672.2 $388,628 - $453,062
-674 Reduced 16.46%
3,421 $2.2 Million
Q3 2020

Nov 16, 2020

SELL
$620.1 - $689.89 $569,871 - $634,008
-919 Reduced 18.33%
4,095 $2.56 Million
Q2 2020

Aug 14, 2020

SELL
$610.05 - $713.9 $1.31 Million - $1.54 Million
-2,154 Reduced 30.05%
5,014 $3.19 Million
Q1 2020

May 15, 2020

SELL
$615.5 - $751.4 $2.17 Million - $2.65 Million
-3,530 Reduced 33.0%
7,168 $4.66 Million
Q4 2019

Feb 14, 2020

BUY
$688.5 - $846.15 $4.15 Million - $5.1 Million
6,032 Added 129.28%
10,698 $8.04 Million
Q3 2019

Nov 14, 2019

BUY
$722.04 - $840.0 $470,770 - $547,680
652 Added 16.24%
4,666 $0
Q2 2019

Aug 14, 2019

SELL
$837.83 - $927.0 $253,024 - $279,954
-302 Reduced 7.0%
4,014 $3.42 Million
Q1 2019

May 15, 2019

SELL
$709.9 - $885.4 $355,659 - $443,585
-501 Reduced 10.4%
4,316 $0
Q4 2018

Feb 14, 2019

BUY
$667.94 - $785.7 $628,531 - $739,343
941 Added 24.28%
4,817 $0
Q3 2018

Nov 13, 2018

SELL
$602.8 - $699.6 $337,568 - $391,776
-560 Reduced 12.62%
3,876 $0
Q2 2018

Aug 10, 2018

BUY
$568.25 - $635.8 $2.16 Million - $2.41 Million
3,798 Added 595.3%
4,436 $0
Q1 2018

May 11, 2018

BUY
$526.8 - $633.85 $111,681 - $134,376
212 Added 49.77%
638 $403,000
Q4 2017

Feb 09, 2018

BUY
$620.6 - $689.35 $264,375 - $293,663
426
426 $269,000

Others Institutions Holding ATRI

About ATRION CORP


  • Ticker ATRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 1,785,990
  • Description
  • Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...
More about ATRI
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.